Fund Holdings — Velan Capital Investment Management LP

Total Portfolio Value:
$141.22M
Total Bought:
$30.10M
Total Sold:
$36.13M
Net Transaction:
-$6.03M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Alimera Sciences Inc13,608,53313,608,5330$42.19M$58.79M41.63%+$16.60M
Heron Therapeutics, Inc.(HRTX)6,986,7446,986,7440$7.20M$11.88M8.41%+$4.68M
Adma Biologics Inc1,736,1002,136,100+400,000$6.22M$9.66M6.84%+$3.44M
Jasper Therapeutics, Inc.(JSPR)11,219,03611,219,0360$7.59M$8.55M6.06%+$964.6K
Tourmaline Bio Inc0319,080+319,080$0$8.35M5.92%+$8.35M
Praxis Precision Medicines, Inc.(PRAX)0345,666+345,666$0$7.70M5.45%+$7.70M
Immunogen Inc189,500189,5000$3.01M$5.62M3.98%+$2.61M
Roivant Sciences Ltd.SHS(ROIV)0500,000+500,000$0$5.62M3.98%+$5.62M
Optinose Inc3,596,8613,796,861+200,000$4.42M$4.90M3.47%+$473.8K
Lantheus Holdings, Inc.(LNTH)75,00075,0000$5.21M$4.65M3.29%-$561.0K
Inspire Medical Systems, Inc.(INSP)15,30018,000+2,700$3.04M$3.66M2.59%+$625.6K
Apellis Pharmaceuticals Inc
COM
50,00050,0000$1.90M$2.99M2.12%+$1.09M
InspireMD, Inc.(NSPR)904,029904,0290$2.96M$2.54M1.80%-$415.9K
Aclaris Therapeutics, Inc.(ACRS)01,761,595+1,761,595$0$1.85M1.31%+$1.85M
Geron Corporation(GERN)778,500778,5000$1.65M$1.64M1.16%-$7.8K
Immunovant, Inc.(IMVT)027,500+27,500$0$1.16M0.82%+$1.16M
enVVeno Medical Corporation(NVNO)0172,235+172,235$0$885.3K0.63%+$885.3K
TELA Bio, Inc.(TELA)746,08777,500-668,587$5.97M$513.0K0.36%-$5.46M
Elevation Oncology Inc497,299497,2990$329.5K$267.1K0.19%-$62.5K
ANNEXON INCCOM(ANNX)459,7460-459,746$1.09M$0—-$1.09M
ASLAN PHARMACEUTICALS LTDSPON ADS NEW625,0000-625,000$1.18M$0—-$1.18M
CABALETTA BIO INCCOM(CABA)150,0000-150,000$2.28M$0—-$2.28M
CULLINAN ONCOLOGY INCCOM(CGEM)75,0000-75,000$678.8K$0—-$678.8K
EDESA BIOTECH INCCOM1,281,6150-1,281,615$810.0K$0—-$810.0K
GOSSAMER BIO INCCOM(GOSS)3,065,1360-3,065,136$2.55M$0—-$2.55M
ICOSAVAX INCCOM160,6300-160,630$1.24M$0—-$1.24M
INFLARX NVCOM(IFRX)200,0000-200,000$596.0K$0—-$596.0K
INHIBRX INCCOM25,0000-25,000$458.8K$0—-$458.8K
MOONLAKE IMMUNOTHERAPEUTICSCLASS A ORD(MLTX)55,3000-55,300$3.15M$0—-$3.15M
PRAXIS PRECISION MEDICINES ICOM5,185,0000-5,185,000$8.87M$0—-$8.87M
QUIPT HOME MEDICAL CORPCOM1,100,0000-1,100,000$5.60M$0—-$5.60M
REZOLUTE INCCOM NEW(RZLT)400,0000-400,000$528.0K$0—-$528.0K
TENET HEALTHCARE CORPCOM NEW(THC)24,9370-24,937$1.64M$0—-$1.64M
Page 1 of 1
Velan Capital Investment Management LP — 13F Holdings — Q4 2023 | TickerTrail